ARVN
Price:
$7.58
Market Cap:
$489.07M
Arvinas, Inc. is a biopharmaceutical company in the clinical development stage, dedicated to identifying, advancing, and marketing innovative therapies designed to eliminate disease-causing proteins. The company's pipeline features several promising candidates. These include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader, currently in Phase I clinical trials, which specifically targets the androgen receptor (AR) protein to treat metastatic castration-resistant prostate cancer (mCRPC) in men. Another key PROTAC protein degrader is ARV-471, which targets the estrogen receptor protein for patients suffering from metastatic ER-positive/HER2-negative breast cancer. Fur...[Read more]
Industry
Biotechnology
IPO Date
2018-09-27
Stock Exchange
NASDAQ
Ticker
ARVN
According to Arvinas, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 410.37M. This represents a change of -25.23% compared to the average of 548.83M of the last 4 quarters.
The mean historical Enterprise Value of Arvinas, Inc. over the last ten years is 1.45B. The current 410.37M Enterprise Value has changed 2.73% with respect to the historical average. Over the past ten years (40 quarters), ARVN's Enterprise Value was at its highest in in the December 2021 quarter at 4.23B. The Enterprise Value was at its lowest in in the June 2017 quarter at 0.
Average
1.45B
Median
1.32B
Minimum
25.82M
Maximum
4.00B
Discovering the peaks and valleys of Arvinas, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.07%
Maximum Annual Enterprise Value = 4.00B
Minimum Annual Increase = -56.44%
Minimum Annual Enterprise Value = 25.82M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 635.71M | -50.63% |
| 2024 | 1.29B | -34.84% |
| 2023 | 1.98B | 13.28% |
| 2022 | 1.74B | -56.44% |
| 2021 | 4.00B | 44.36% |
| 2020 | 2.77B | 105.71% |
| 2019 | 1.35B | 232.56% |
| 2018 | 405.39M | 34.17% |
| 2017 | 302.14M | 1.07% |
The current Enterprise Value of Arvinas, Inc. (ARVN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.30B
5-year avg
1.93B
10-year avg
1.45B
Arvinas, Inc.’s Enterprise Value is less than Valneva SE (537.77M), less than ArriVent BioPharma, Inc. Common Stock (1.36B), less than Day One Biopharmaceuticals, Inc. (2.03B), less than Astria Therapeutics, Inc. (626.31M), less than Replimune Group, Inc. (686.64M), less than MeiraGTx Holdings plc (904.12M), less than Iovance Biotherapeutics, Inc. (1.31B), less than Geron Corporation (918.81M), less than Ginkgo Bioworks Holdings, Inc. (782.25M), less than Erasca, Inc. (4.37B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 537.77M | $507.78M | |
| 1.36B | $1.42B | |
| 2.03B | $2.22B | |
| 626.31M | $718.13M | |
| 686.64M | $733.24M | |
| 904.12M | $888.13M | |
| 1.31B | $1.46B | |
| 918.81M | $737.75M | |
| 782.25M | $515.41M | |
| 4.37B | $4.37B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arvinas, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Arvinas, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Arvinas, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Arvinas, Inc. (ARVN)?
What is the 3-year average Enterprise Value for Arvinas, Inc. (ARVN)?
What is the 5-year average Enterprise Value for Arvinas, Inc. (ARVN)?
How does the current Enterprise Value for Arvinas, Inc. (ARVN) compare to its historical average?